Crouther Marilyn C

Director · CPRI, ICFI

As of 2026-09-16, Crouther Marilyn C has 10 Form 4 transactions on record across 2 companies — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $1.3MIndirect: $0$1.3Mas of 2026-09-16
  • Direct $1.3M
  • Indirect $0
ICFIdirect10,859 sh$950K
CPRIdirect24,212 sh$357K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

CPRI · 8 trades
2026-07-29: Award / grant, 11,055 sh ($0)2026-07-29: Option exercise, 8,426 sh ($0)2026-07-29: Option exercise, 8,426 sh2026-07-29: Option exercise, 8,426 sh2025-08-07: Award / grant, 8,426 sh ($0)2025-08-07: Option exercise, 4,854 sh ($0)2025-08-07: Option exercise, 4,854 sh2025-08-07: Option exercise, 4,854 sh
ICFI · 2 trades
2026-07-01: Award / grant, 2,277 sh ($0)2025-07-01: Award / grant, 1,720 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
10 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-07-29CPRIAward / grant11,05511,055Form 4
2026-07-29CPRIOption exercise8,4260Form 4
2026-07-29CPRIOption exercise8,42624,212Form 4
2026-07-29CPRIOption exercise8,42624,212Form 4
2026-07-01ICFIAward / grant2,27710,859Form 4
2025-08-07CPRIAward / grant8,4268,426Form 4
2025-08-07CPRIOption exercise4,8540Form 4
2025-08-07CPRIOption exercise4,85415,786Form 4
2025-08-07CPRIOption exercise4,85415,786Form 4
2025-07-01ICFIAward / grant1,7208,582Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.